Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACAP2 intronic transcript 1 (ACAP2-IT1) is a long non-coding RNA transcribed from within an intron of the ACAP2 gene. It is not a protein-coding transcript, receptor, enzyme, transporter, or other classical drug target. There is no established function or disease association for ACAP2-IT1, nor is it implicated as a biomarker or drug target in any current literature. Intronic non-coding RNAs, in general, may play roles in the regulation of host gene expression or RNA splicing, but no specific data are available for this transcript[2][1]. There are no reports suggesting ACAP2-IT1 is a therapeutic target or that it interacts with drugs. If you are seeking a classical target (protein, enzyme, receptor), the ACAP2 protein itself (Arf-GAP with coiled-coil, ankyrin repeat and PH domains 2) is an entirely distinct entity and should not be confused with ACAP2-IT1[5]. In summary, "ACAP2 intronic transcript 1 (ACAP2-IT1)" is not a conventional molecular target. It is a non-coding transcript of uncertain function. If you require information on a protein or therapeutic target, refer to "ACAP2" (the protein) instead.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACAP2 intronic transcript 1 (ACAP2-IT1).